Notice to Stakeholders: Statement on the Investigational Use of Marketed Drugs in Clinical Trials

Name: Notice to Stakeholders: Statement on the Investigational Use of Marketed Drugs in Clinical Trials
Creator: Health Canada
License: https://open.canada.ca/en/open-government-licence-canada

Notice to Stakeholders: Statement on the Investigational Use of Marketed Drugs in Clinical Trials is an open dataset from Health Canada with 2 files (HTML); catalogue record updated 2022-06-07. On CanQuery you can follow the original downloads. Files are available in English and French.

This statement provides guidance to clinical trial applicants about the investigational use of marketed drugs within clinical trials in Canada.

Publisher: Health Canada
Resources: 2
Catalogue metadata updated: 2022-06-07

Data overview

Formats: HTML
File languages: English, French

Official sources and licences

Government of Canada Open Data
Open Government Licence – Canada

Resources

Notice to Stakeholders: Statement on the Investigational Use of Marketed Drugs in Clinical Trials (English, HTML) HTML · Download HTML
Notice to Stakeholders: Statement on the Investigational Use of Marketed Drugs in Clinical Trials (French, HTML) HTML · Download HTML

Related open data

Health Canada